● Autologous NK cell injection is China's first in class and entered clinical phase I trials ● NK, DC-CIK,CAR-NK、 T cell process development and production platform ● Animmune cell technology research team ● Complexed analytical method development and method validation
E-mail ：doublle@doubllebio.com
Tel：+86 020 32053707
Address：8th Floor Building B1 11 Kaiyuan Avenue Guangzhou Guangdong, CN